Evidence map›Paper›PMID 31262759›Full record

ArticleAntimicrobial agents and chemotherapy2019

Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.

Keivan Zandi, Franck Amblard, Sarah Amichai, Leda Bassit, Sijia Tao, Yong Jiang, Longhu Zhou, Olivia Ollinger Russell, Seema Mengshetti, Raymond F Schinazi

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Potential Antiviral Compounds fromMolecules (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Synthesis and biological evaluation of new β-D-NBioorganic & medicinal chemistry letters · 2023
    Article
  5. Article
  6. Bis(Benzofuran-1,3-International journal of molecular sciences · 2022
    Article
  7. Article
  8. Anno 2021: Which antivirals for the coming decade?Annual reports in medicinal chemistry · 2021
    Article
  9. Repurposing Nucleoside Analogs for Human Coronaviruses.Antimicrobial agents and chemotherapy · 2020
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Keivan ZandiCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Franck AmblardCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Sarah AmichaiCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Leda BassitCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Sijia TaoCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Yong JiangCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Longhu ZhouCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Olivia Ollinger RussellCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Seema MengshettiCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Raymond F SchinaziCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA rschina@emory.edu.

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Repurposing drugs to prevent and inhibit Zika virus inflectionsR21AI129607 · NIAID · EMORY UNIVERSITY · PI SCHINAZI, RAYMOND FELIX · 2017 to 2018
$429k
NIAID NIH HHS P30 AI050409NIAID NIH HHS R21 AI129607
6 · The paper itself

Abstract

Yellow fever virus (YFV) is a human

Indexed as

AfricaAnimalsAntiviral AgentsBrazilCell Line, TumorChlorocebus aethiopsHumansMolecular StructureNucleosidesVero CellsYellow FeverYellow fever virusAntiviral AgentsNucleosidesantiviral agentsFlaviviridaenucleoside analogsyellow fever virus

Identifiers

PMID31262759
PMCPMC6709485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.